Loading...
    Loading...
    LEADERBOARD
labroots
Login here
Register Free
  • LOGIN
  • REGISTER FREE
  • Home
  • Virtual Events
      • Upcoming
      • On-Demand
      • Companies
      • Posters
      • Categories
      See More
      See More
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Webinars
      • Upcoming
      • On-Demand
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Trending News
      • Most Recent
      • What's Hot
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Drug Discovery & Development
      • Plants & Animals
      • Cannabis Sciences
      • Earth & The Environment
      • Space & Astronomy
      • Chemistry & Physics
      • Technology
  • Multimedia
      • Sponsored Content
      • eBooks
      • Podcasts
      • Infographics
      See More
      See More
      See More
      See More
  • Products
      • Categories
      • Companies
      • New
      • Popular
      Antibodies
      Immunity, Immunoassay, Immunotherapy
      Assay Kits
      Detection, Quantification
      Biomolecules
      Proteins
      Cell Biology
      Cell function
      Cell-Based Assays
      Cell viability
      Cell/Tissue Culture
      Cell lines, Cell growth, Cell differentiation
      Chemicals and Reagents
      Reagent kits, Laboratory chemicals
      Drug Discovery and Development
      Target identification, High-throughput screening
      Flow Cytometry
      Immunophenotyping, Cell cycle analysis
      Genomics
      Genome sequencing, Transcriptomics
      Imaging (Bio-Imaging / Microscopy)
      Fluorescence imaging
      Lab Automation
      High-throughput screening, Robotics, Liquid handling systems
      Lab Equipment
      Centrifuges, Incubators, Homogenizers, Sonicators
      Life Sciences
      Biological research, Biotechnology
      Molecular Biology
      DNA replication, Gene expression, PCR
      Next Gen Sequencing
      DNA sequencing, High-throughput sequencing, NGS platforms, RNA sequencing, miRNA sequencing, Accessory Products
      Quality Control and Validation
      QC standards, Quality assurance
      Single Cell Analysis
      Transcriptomics
      Technology
      Biotechnology, Instrumentation, Data analysis
      See More
      See More
      See More
  • Companies
      • See More
    • Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        See More
        See More
        See More
        Gift Card $25
        Gift Card $50
        Gift Card $75
        Gift Card $100
        See More
        Labroots Store Gift Card Balance
        $0.00
        Balance
        Gift Card Number:

        No gift card matches the entered value.

    • Continuing Education
    • More
      • Virtual Events
        • All Virtual Events
        • Upcoming
        • On-Demand
        • Posters
        • Companies
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Webinars
        • All Webinars
        • Upcoming
        • On-Demand
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Trending News
        • Most Recent
        • What's Hot
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Drug Discovery & Development
        • Plants & Animals
        • Cannabis Sciences
        • Earth & The Environment
        • Space & Astronomy
        • Chemistry & Physics
        • Technology
        Multimedia
        • Sponsored Content
        • eBooks
        • Podcasts
        • Infographics
        Companies
        Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        Continuing Education
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Blog
        • Scholarships
        • RSS
        • Contact Us
        • Continuing Education
        • Leaderboard
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        • Service Level Agreement
        Support
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Media Partnerships
        • Blog
        • Scholarships
        • Continuing Education
        • Leaderboard
        • Contact Us
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        • Service Level Agreement
        Request Demo
        Interested in Advertising
        with Labroots?
        Have questions? Visit our Support pages
    Login here
    Register Free
    Follow

    Clinical Medicine

    Clinical Medicine: is a field of medicine that deals primarily with the practice and study of medicine based on the direct examination of the patient. This is in contrast to other science fields that focus more on the theoretical and basics of medical science. In clinical medicine, medical practitioners assess patients in order to diagnose, treat, and prevent disease.

    Webinars

    • OCT 17, 2013 | 2:00 PM
      C.E. CREDITS
      Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic cancer
      Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic...
      Pancreatic cancer is the 4th most common cause of cancer deaths in the United States. Due to the aggressive nature of this cancer and the lack of biomarkers for early detection, the incidence...
      Speaker: Antonio T. Baines, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      73
      OCT 17, 2013 | 12:00 PM
      C.E. CREDITS
      Embracing the Complexity of Cancer: Seeing the Forest and the Trees
      Embracing the Complexity of Cancer: Seeing the Forest and the...
      Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
      Speaker: Kenneth Buetow, PhD, FACMI
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      34
      OCT 17, 2013 | 12:00 PM
      Biomarkers & Dx test development
      Biomarkers & Dx test development
      The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spit...
      Speaker: Martin Latterich, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      36
      OCT 17, 2013 | 11:00 AM
      C.E. CREDITS
      The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
      The Need for Critical Reassessment of Current Strategies for Cancer...
      Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
      Speaker: George Poste, DVM, DSc, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      42
      OCT 17, 2013 | 10:00 AM
      C.E. CREDITS
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
      Speaker: Donald Tindall, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      40
      OCT 17, 2013 | 8:00 AM
      Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
      Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
      Many drugs currently used for anti-cancer therapy demonstrate significant inter-individual variability that cannot be normalized using body weight or body surface area. There is an increasing...
      Speaker: William Clarke, PhD, MBA, DABCC
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      264
      OCT 17, 2013 | 8:00 AM
      C.E. CREDITS
      Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
      Next-generation Cancer Care in the Age of Genomics, Precision...
      Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
      Speaker: C Jimmy Lin, MD, PhD, MHS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      52
      OCT 17, 2013 | 7:00 AM
      C.E. CREDITS
      Monitoring for Chemotherapy Toxicity and Cardiac Troponin
      Monitoring for Chemotherapy Toxicity and Cardiac Troponin
      Recent data have confirmed the ability of cardiac troponin (cTn) measurements to identify those who are developing cardiotoxicity in response to potentially cardiotoxic chemotherapeutic agen...
      Speaker: Allan Jaffe, M.D.
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      32
      OCT 17, 2013 | 6:00 AM
      A Bioinformatics Approach to Clinical Sequencing
      A Bioinformatics Approach to Clinical Sequencing
      The widespread adoption of precision medicine in oncology requires: a compendium of therapies targeting the genetic vulnerabilities of cancer; the diagnostic tools capable of generating a pr...
      Speaker: Dan Rhodes, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 3:00 PM
      C.E. CREDITS
      Recent Developments in the treatment of Melanoma
      Recent Developments in the treatment of Melanoma
      While Melanoma is very curable and treatable when detected early, late stage melanoma has had a very poor outcome. In 2013, it is estimated that over 80,000 patients in the US will develop me...
      Speaker: Adil Daud, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      36
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
      Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
      Speaker: Kristin Landis-Piwowar, PhD, MLS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      129
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
      Resistance to AR Signaling Inhibitors in Castration Resistant...
      While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
      Speaker: Elahe A Mostaghel, MD, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 12:00 PM
      C.E. CREDITS
      New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
      New therapeutic strategies and new modes of drug resistance: From...
      The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
      Speaker: Katherine LB Borden, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      60
      OCT 16, 2013 | 11:00 AM
      C.E. CREDITS
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
      Speaker: Ross L. Cagan, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      78
      OCT 16, 2013 | 11:00 AM
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
      "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
      Speaker: Fred Kramer, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      90
      OCT 16, 2013 | 11:00 AM
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
      Speaker: Michael J Mann, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      58
      OCT 16, 2013 | 10:00 AM
      C.E. CREDITS
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
      The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
      Speaker: Anna Barker, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      37
      OCT 16, 2013 | 9:00 AM
      C.E. CREDITS
      Keynote: Breast Cancer Genomics and Genetics
      Keynote: Breast Cancer Genomics and Genetics
      It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
      Speaker: Charles M. Perou, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      132
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
      Prognostic, predictive, and surrogate biomarkers in men with castration...
      With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
      Speaker: Andrew Armstrong, MD ScM FACP
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      96
      AUG 22, 2013 | 3:00 PM
      Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
      Next-generation Cancer Care in the Age of Genomics, Precision...
      Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
      Speaker: C Jimmy Lin, MD, PhD, MHS
      Presented at: Genetics and Genomics Virtual Event Series 2013
      114
      AUG 22, 2013 | 3:00 PM
      C.E. CREDITS
      Evaluation challenges and regulatory considerations for next-generation sequencing and other high throughput genomic technology based clinical applications
      Evaluation challenges and regulatory considerations for next-generation...
      The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...
      Speaker: Živana Težak, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      282
      AUG 22, 2013 | 2:00 PM
      Translation and Clinical Application of Innovative Genomic Analysis: Challenges Remain
      Translation and Clinical Application of Innovative Genomic Analysis:...
      The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...
      Speaker: Paul Billings, MD, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      92
      AUG 22, 2013 | 2:00 PM
      The Road to Genomic Medicine is Paved with Data and Information
      The Road to Genomic Medicine is Paved with Data and Information
      Since the introduction of second-generation DNS sequencing technologies in 2007, the cost of genome sequencing has been consistently by 33% per quarter, with the $1000 genome arriving in 2012...
      Speaker: John Quackenbush, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      110
      AUG 22, 2013 | 1:00 PM
      Embracing the Complexity of Cancer: Seeing the Forest and the Trees
      Embracing the Complexity of Cancer: Seeing the Forest and the...
      Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
      Speaker: Kenneth Buetow, PhD, FACMI
      Presented at: Genetics and Genomics Virtual Event Series 2013
      92
    OCT 17, 2013 | 2:00 PM
    C.E. CREDITS
    Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic cancer
    Oncoproteins K-Ras and Pim kinases as molecular targets in pancreatic...
    Pancreatic cancer is the 4th most common cause of cancer deaths in the United States. Due to the aggressive nature of this cancer and the lack of biomarkers for early detection, the incidence...
    Speaker: Antonio T. Baines, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    73
    OCT 17, 2013 | 12:00 PM
    C.E. CREDITS
    Embracing the Complexity of Cancer: Seeing the Forest and the Trees
    Embracing the Complexity of Cancer: Seeing the Forest and the...
    Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
    Speaker: Kenneth Buetow, PhD, FACMI
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    34
    OCT 17, 2013 | 12:00 PM
    Biomarkers & Dx test development
    Biomarkers & Dx test development
    The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spit...
    Speaker: Martin Latterich, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    36
    OCT 17, 2013 | 11:00 AM
    C.E. CREDITS
    The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
    The Need for Critical Reassessment of Current Strategies for Cancer...
    Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
    Speaker: George Poste, DVM, DSc, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    42
    OCT 17, 2013 | 10:00 AM
    C.E. CREDITS
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
    Speaker: Donald Tindall, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    40
     
     
  • OCT 17, 2013 | 8:00 AM
    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
    Many drugs currently used for anti-cancer therapy demonstrate significant inter-individual variability that cannot be normalized using body weight or body surface area. There is an increasing...
    Speaker: William Clarke, PhD, MBA, DABCC
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    264
    OCT 17, 2013 | 8:00 AM
    C.E. CREDITS
    Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
    Next-generation Cancer Care in the Age of Genomics, Precision...
    Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
    Speaker: C Jimmy Lin, MD, PhD, MHS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    52
    OCT 17, 2013 | 7:00 AM
    C.E. CREDITS
    Monitoring for Chemotherapy Toxicity and Cardiac Troponin
    Monitoring for Chemotherapy Toxicity and Cardiac Troponin
    Recent data have confirmed the ability of cardiac troponin (cTn) measurements to identify those who are developing cardiotoxicity in response to potentially cardiotoxic chemotherapeutic agen...
    Speaker: Allan Jaffe, M.D.
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    32
    OCT 17, 2013 | 6:00 AM
    A Bioinformatics Approach to Clinical Sequencing
    A Bioinformatics Approach to Clinical Sequencing
    The widespread adoption of precision medicine in oncology requires: a compendium of therapies targeting the genetic vulnerabilities of cancer; the diagnostic tools capable of generating a pr...
    Speaker: Dan Rhodes, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 3:00 PM
    C.E. CREDITS
    Recent Developments in the treatment of Melanoma
    Recent Developments in the treatment of Melanoma
    While Melanoma is very curable and treatable when detected early, late stage melanoma has had a very poor outcome. In 2013, it is estimated that over 80,000 patients in the US will develop me...
    Speaker: Adil Daud, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    36
     
     
  • OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
    Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
    Speaker: Kristin Landis-Piwowar, PhD, MLS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    129
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
    Resistance to AR Signaling Inhibitors in Castration Resistant...
    While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
    Speaker: Elahe A Mostaghel, MD, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 12:00 PM
    C.E. CREDITS
    New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
    New therapeutic strategies and new modes of drug resistance: From...
    The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
    Speaker: Katherine LB Borden, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    60
    OCT 16, 2013 | 11:00 AM
    C.E. CREDITS
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
    Speaker: Ross L. Cagan, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    78
    OCT 16, 2013 | 11:00 AM
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
    "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
    Speaker: Fred Kramer, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    90
     
     
  • OCT 16, 2013 | 11:00 AM
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
    Speaker: Michael J Mann, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    58
    OCT 16, 2013 | 10:00 AM
    C.E. CREDITS
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
    The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
    Speaker: Anna Barker, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    37
    OCT 16, 2013 | 9:00 AM
    C.E. CREDITS
    Keynote: Breast Cancer Genomics and Genetics
    Keynote: Breast Cancer Genomics and Genetics
    It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
    Speaker: Charles M. Perou, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    132
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
    Prognostic, predictive, and surrogate biomarkers in men with castration...
    With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
    Speaker: Andrew Armstrong, MD ScM FACP
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    96
    AUG 22, 2013 | 3:00 PM
    Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
    Next-generation Cancer Care in the Age of Genomics, Precision...
    Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
    Speaker: C Jimmy Lin, MD, PhD, MHS
    Presented at: Genetics and Genomics Virtual Event Series 2013
    114
     
     
  • AUG 22, 2013 | 3:00 PM
    C.E. CREDITS
    Evaluation challenges and regulatory considerations for next-generation sequencing and other high throughput genomic technology based clinical applications
    Evaluation challenges and regulatory considerations for next-generation...
    The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...
    Speaker: Živana Težak, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    282
    AUG 22, 2013 | 2:00 PM
    Translation and Clinical Application of Innovative Genomic Analysis: Challenges Remain
    Translation and Clinical Application of Innovative Genomic Analysis:...
    The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...
    Speaker: Paul Billings, MD, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    92
    AUG 22, 2013 | 2:00 PM
    The Road to Genomic Medicine is Paved with Data and Information
    The Road to Genomic Medicine is Paved with Data and Information
    Since the introduction of second-generation DNS sequencing technologies in 2007, the cost of genome sequencing has been consistently by 33% per quarter, with the $1000 genome arriving in 2012...
    Speaker: John Quackenbush, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    110
    AUG 22, 2013 | 1:00 PM
    Embracing the Complexity of Cancer: Seeing the Forest and the Trees
    Embracing the Complexity of Cancer: Seeing the Forest and the...
    Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
    Speaker: Kenneth Buetow, PhD, FACMI
    Presented at: Genetics and Genomics Virtual Event Series 2013
    92
    Related Tags
    See more See less
    Let's Talk Science. Let's Talk Medicine.

    The leading scientific social networking website and producer of educational virtual events and webinars.

    About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance
    Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati
    © 2008-2025 Labroots Inc.
    Opens in a new window Opens an external site Opens an external site in a new window
    Modal title